Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
NCT06549842
Summary
The Safe and Fast Radial Hemostasis using Synergistic Strategies (SAFE \& FAST) trial is an interventional study aimed at reducing the incidence of radial artery occlusion (RAO) rebound bleeding, and the required compression time after transradial approach (TRA) procedures, which have become the default access for coronary procedures globally. The hypothesis is that combining lower-dose heparin and radial hemostasis with simultaneous ipsilateral ulnar artery compression could achieve these improved outcomes.
Eligibility
Inclusion Criteria: 1. Patients referred for diagnostic transradial cardiac catheterization 2. Age ≥ 18 years 3. Ability to provide written informed consent Exclusion Criteria: 1. Absence of written informed consent 2. Patients on long-term systemic anticoagulation therapy for a different indication 3. Patients requiring a heparin dose of greater than 50 units per kilogram before, during, or after the procedure for any reason. 4. Patients requiring greater than 6 French catheter access
Conditions6
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06549842